tiprankstipranks
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
US Market

PharmaCyte Biotech (PMCB) Financial Statements

Compare
226 Followers

PharmaCyte Biotech Financial Overview

PharmaCyte Biotech's market cap is currently $11.36M. The company's EPS TTM is $0.545; its P/E ratio is 2.99; PharmaCyte Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -6.52M$ -6.46M$ -4.39M$ -3.62M$ -3.83M
EBITDA$ 0.00$ 0.00$ 0.00$ 0.00$ -3.83M
Net Income$ 333.76K$ -4.32M$ -4.09M$ -3.55M$ -3.83M
Balance Sheet
Cash & Short-Term Investments$ 50.18M$ 68.04M$ 85.40M$ 2.20M$ 894.86K
Total Assets$ 59.90M$ 73.28M$ 90.62M$ 7.40M$ 6.17M
Total Debt$ 0.00$ 0.00$ 0.00$ 50.80K$ 75.20K
Net Debt$ -50.18M$ -68.04M$ -85.40M$ -2.15M$ -819.66K
Total Liabilities$ 20.39M$ 586.58K$ 704.37K$ 724.78K$ 1.08M
Stockholders' Equity$ 39.51M$ 72.69M$ 89.92M$ 6.68M$ 5.09M
Cash Flow
Free Cash Flow$ -2.15M$ -3.79M$ -4.12M$ -3.33M$ -2.34M
Operating Cash Flow$ -2.15M$ -3.79M$ -4.12M$ -3.33M$ -2.34M
Investing Cash Flow$ -5.00M$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ -10.71M$ -13.56M$ 87.31M$ 4.64M$ 2.73M
Currency in USD

PharmaCyte Biotech Earnings and Revenue History

PharmaCyte Biotech Debt to Assets

PharmaCyte Biotech Cash Flow

PharmaCyte Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis